Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Vaccines and Vision for the Work Ahead
Shots In The Dark: Why Access To A Covid-19 Vaccine Isn’t Guaranteed
From Patients to Patents: A Focus on Health Equity
Building Racial Equity into the Drug Development System
#HowWeHeal from Racism: Structural Racism in the Medicines System
AbbVie Proves Masterful at Playing Drug Patent Game
AbbVie uses dozens of patents to ward off competition for a pricey cancer medicine
AbbVie, already famous for its Humira strategy, forms another ‘patent wall’ around Imbruvica: report
Remdesivir: US purchase of world stocks sparks new “hunger games,” warn observers
I-MAK’s response to the senseless killings of Black people with impunity